WallStreetZenWallStreetZen

NYSEMKT: ERNA
Eterna Therapeutics Inc Stock

$3.22-0.27 (-7.74%)
Updated Mar 20, 2023
ERNA Price
$3.22
Fair Value Price
N/A
Market Cap
$16.51M
52 Week Low
$2.74
52 Week High
$45.76
P/E
-0.4x
P/B
1.36x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$24.58M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.84
Operating Cash Flow
-$21M
Beta
0.85
Next Earnings
Apr 14, 2023
Ex-Dividend
N/A
Next Dividend
N/A

ERNA Overview

NTN Buzztime, Inc. engages in the provision of entertainment and innovative technology services. The company is headquartered in Carlsbad, California and currently employs 94 full-time employees. The firm provides an entertainment and marketing services platform for hospitality venues that offers games, events, and entertainment experiences to their customers. Its customers offer guests trivia, card, sports and arcade games, nationwide competitions, and self-service dining features, including dynamic menus, touchscreen ordering and secure payment by licensing the Company's customizable solution. Its platform creates connections among the players and venues. Its network subscriber venues are related to national and regional restaurant brands, including Buffalo Wild Wings, Old Chicago, Beef O'Brady's, Aroogas, Buffalo Wings & Rings, Native New Yorker and Boston Pizza. Its entertainment system enables players to interact at the venue, and it also enables competition between venues, referred to as multiplayer gaming.

Zen Score

Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ERNA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ERNA is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ERNA is good value based on its book value relative to its share price (1.36x), compared to the US Biotechnology industry average (4.81x)
P/B vs Industry Valuation
ERNA is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more ERNA due diligence checks available for Premium users.

Be the first to know about important ERNA news, forecast changes, insider trades & much more!

ERNA News

Valuation

ERNA price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.4x
Industry
16.1x
Market
22.37x

ERNA price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.36x
Industry
4.81x
ERNA is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ERNA's financial health

Profit margin

Revenue
$0.0
Net Income
-$4.5M
Profit Margin
0%
ERNA's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$22.3M
Liabilities
$10.2M
Debt to equity
0.84
ERNA's short-term assets ($13.68M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ERNA's short-term assets ($13.68M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ERNA's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ERNA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$5.4M
Investing
$129.0k
Financing
$7.6M
ERNA's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ERNA vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
ERNA$16.51M-7.74%-0.40x1.36x
BWV$16.55M-0.95%-0.95x0.74x
CMMB$16.46M+1.36%-0.62x0.45x
SQZ$16.32M+0.73%-0.20x0.24x
HGEN$16.79M-6.00%-0.10x-0.32x

Eterna Therapeutics Stock FAQ

What is Eterna Therapeutics's quote symbol?

NYSEMKT: ERNA) Eterna Therapeutics trades on the NYSEMKT under the ticker symbol ERNA. Eterna Therapeutics stock quotes can also be displayed as NYSEMKT: ERNA.

If you're new to stock investing, here's how to buy Eterna Therapeutics stock.

What is the 52 week high and low for Eterna Therapeutics (NYSEMKT: ERNA)?

(NYSEMKT: ERNA) Eterna Therapeutics's 52-week high was $45.76, and its 52-week low was $2.74. It is currently -92.96% from its 52-week high and 17.73% from its 52-week low.

How much is Eterna Therapeutics stock worth today?

(NYSEMKT: ERNA) Eterna Therapeutics currently has 5,127,070 outstanding shares. With Eterna Therapeutics stock trading at $3.22 per share, the total value of Eterna Therapeutics stock (market capitalization) is $16.51M.

Eterna Therapeutics stock was originally listed at a price of $2,000.00 in Dec 31, 1997. If you had invested in Eterna Therapeutics stock at $2,000.00, your return over the last 25 years would have been -99.84%, for an annualized return of -22.68% (not including any dividends or dividend reinvestments).

How much is Eterna Therapeutics's stock price per share?

(NYSEMKT: ERNA) Eterna Therapeutics stock price per share is $3.22 today (as of Mar 20, 2023).

What is Eterna Therapeutics's Market Cap?

(NYSEMKT: ERNA) Eterna Therapeutics's market cap is $16.51M, as of Mar 21, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Eterna Therapeutics's market cap is calculated by multiplying ERNA's current stock price of $3.22 by ERNA's total outstanding shares of 5,127,070.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.